경폐 약물 전달 시스템 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별: 규모, 점유율, 전망, 기회 분석(2023-2030년)
Pulmonary Drug Delivery Systems Market, By Product type, By Application, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
상품코드
:
1349949
리서치사
:
Coherent Market Insights
발행일
:
2023년 07월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 경폐 약물 전달 시스템 시장은 2023년 343억 4,400만 달러에 달할 것으로 추정 및 예측되며, 예측 기간(2023-2030년) 동안 4.6%의 CAGR을 나타낼 것으로 예상됩니다.
| 보고 대상 범위 |
보고서 상세 |
| 기준년도 |
2022 |
2023년 시장 규모 |
343억 4,000만 달러 |
| 과거 데이터 |
2018년부터 2021년까지 |
예측 기간 |
2023-2030 |
| 예측 기간(2023-2030년)의 CAGR: |
4.60% |
2030년 가치 예측 |
470억 5,000만 달러 |
경폐 약물 전달은 환자가 흡입기를 사용하여 약물을 흡입하고 약물이 폐 점막을 통해 혈류에 흡수되는 투여 경로입니다. 폐 약물 전달은 호흡기 질환 치료에서 질병에 직접 접근할 수 있는 반면, 약물의 전신 흡수를 위해 방대한 표면적과 상대적으로 적은 효소가 있는 통제된 환경을 제공합니다.
경폐 약물 전달은 정맥, 경구, 협부, 경피, 질, 비강, 안과적 투여와 비교하여 전신 질환 치료의 투여 경로로서 몇 가지 장점이 있습니다.
시장 역학
주요 시장 기업들은 제품 포트폴리오를 확장하기 위해 규제 당국의 제품 승인과 같은 유기적 성장 전략에 초점을 맞추고 있으며, 이는 예측 기간 동안 세계 경폐 약물 전달 시스템 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2020년 7월 제약회사 노바티스(Novartis AG)는 유럽위원회(EC)가 성인 환자의 천식 유지 요법으로 에너자이르 브리즈할러(Enerzair Breezhaler)를 승인했다고 발표했습니다. 이 승인에는 흡입 확인, 약물 복용 알림, 객관적인 데이터에 대한 액세스를 제공하고 치료 결정을 더 잘 지원할 수 있는 센서와 앱이 있는 디지털 컴패니언(선택 사항)도 포함되어 있습니다.
폐 질환 치료를 위한 주요 시장 기업들의 연구개발 활동이 활발해짐에 따라 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2020년 12월 인타스 파마슈티컬스(Intas Pharmaceuticals Ltd.)는 구강 내 붕괴 정제 기술을 통해 천식 및 만성폐쇄성폐질환과 같은 호흡기 질환의 치료에 근본적인 이점을 가진 첨단 흡입제 개발에 집중하고 있다고 발표했습니다. 이 약물 전달 시스템은 제품이 빠르게 분해되도록 설계되어 보다 빠른 약효 발현을 보장합니다. 이 기술은 소아, 노인 및 정신과 호흡기 질환 환자에게 쉽게 투여할 수 있도록 여러 분자에 적용되어 환자의 순응도를 높이고 복용 편의성을 향상시킵니다.
본 조사의 주요 특징
- 이 보고서는 세계 경폐 약물 전달 시스템 시장을 심층 분석하고 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR)을 제공합니다.
- 또한 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
- 세계 경폐 약물 전달 시스템 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과 및 전략과 같은 매개 변수를 기반으로 프로파일링합니다.
- 이 조사 대상의 주요 기업으로는 3M Health Care, Allied Healthcare Products, Inc. GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co. Respiratory Equipment, Inc. 및 Koninklijke Philips N.V. 등이 있습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 경폐 약물 전달 시스템 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계 경폐 약물 전달 시스템 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 상황 개요
- 보고서 개요
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 최근 제품 출시
- 역학
- 합병, 인수, 제휴
- 규제 시나리오
- 주요 발전
- PEST 분석
- 파트너십 시나리오
- 브랜드와 가격 분석
- 유통업체 상황
- Porter의 Five Forces 분석
- 기술적 진보
- 주요 발전
- 시장 동향
제4장 세계의 경폐 약물전달 시스템 시장 - COVID-19의 영향 분석
- 경제적 영향
- COVID-19 역학
- 수급에 대한 영향
제5장 세계의 경폐 약물전달 시스템 시장 : 제품 유형별, 2018-2030년
- 네뷸라이저
- 건조 분말 흡입기(DPI)
- 정량 흡입기(MDI)
제6장 세계의 경폐 약물전달 시스템 시장 : 용도별, 2018-2030년
- 천식
- 만성 폐쇄성 폐질환(COPD)
- 낭포성 섬유증
- 알레르기성 비염
- 기타
제7장 세계의 경폐 약물전달 시스템 시장 : 유통 채널별, 2018년-2030년
제7장 세계의 경폐 약물전달 시스템 시장 : 유통 채널별, 2018년-2030년
제8장 세계의 경폐 약물전달 시스템 시장 : 지역별, 2018년-2030년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카
제9장 경쟁 구도
- 3M Health Care
- Allied Healthcare Products, Inc.
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- CareFusion Corporation
- GF Health Products, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Omron Healthcare, Inc.
- Glenmark Pharmaceuticals
- PARI Respiratory Equipment, Inc.
- Koninklijke Philips N.V.
제10장 섹션
LSH
영문 목차
The global pulmonary drug delivery systems market is estimated to be valued at US$ 34.34 billion in 2023 and is expected to exhibit a CAGR of 4.6% during the forecast period (2023-2030).
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 34.34 Bn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
4.60% |
2030 Value Projection: |
US$ 47.05 Bn |
Pulmonary drug delivery is a route of administration in which patients use an inhaler to inhale its medications, and drugs are absorbed into the bloodstream via the lung mucous membrane. It provides direct access to disease in the treatment of respiratory diseases, while providing an enormous surface area and a relatively low enzymatic, controlled environment for systemic absorption of medications.
Pulmonary drug delivery offers several advantages as a route of administration for the treatment of systemic diseases compared with intravenous, oral, buccal, transdermal, vaginal, nasal or ocular administration.
Market Dynamics
The key market players are focused on organic growth strategies such as product approval by regulatory authorities to expand its product portfolio is expected to drive the global pulmonary drug delivery systems market growth over the forecast period. For instance, in July 2020, Novartis AG, a pharmaceutical company, announced that the European Commission (EC) has approved Enerzair Breezhaler, as a maintenance treatment of asthma in adult patients. The approval also includes an optional digital companion with sensor and app that provides inhalation confirmation, medication reminders and access to objective data to better support therapeutic decisions.
The increasing research and development activities by key market players for the treatment of pulmonary diseases is expected to drive the market growth over the forecast period. For instance, in December 2020, Intas Pharmaceuticals Ltd., announced that the company was focused on developing advanced inhalation formulation having fundamental advantages in the therapy of diseases of the respiratory tract, including asthma and Chronic Obstructive Pulmonary Disease with Orally Disintegrating Tablet Technology. The Drug delivery system designed for rapid disintegration of the product ensuring faster onset of action. This technology is used for several molecules to facilitate ease of administration and improved patient compliance & convenient dosing for paediatric, geriatric, and psychiatric patients with respiratory diseases.
Key features of the study:
- This report provides an in-depth analysis of the global pulmonary drug delivery systems market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pulmonary drug delivery systems marketbased on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include 3M Health Care, Allied Healthcare Products, Inc., AstraZeneca, Boehringer Ingelheim International GmbH., CareFusion Corporation, GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Omron Healthcare, Inc., Glenmark Pharmaceuticals, PARI Respiratory Equipment, Inc., and Koninklijke Philips N.V.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global pulmonary drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pulmonary drug delivery systems market
Detailed Segmentation:
- Global Pulmonary Drug Delivery Systems Market, By Product Type:
- Nebulizers
- Dry Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Global Pulmonary Drug Delivery Systems Market, By Application:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Allergic Rhinitis
- Others
- Global Pulmonary Drug Delivery Systems Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Pulmonary Drug Delivery Systems Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- 3M Health Care
- Allied Healthcare Products, Inc.
- straZeneca
- Boehringer Ingelheim International GmbH.
- CareFusion Corporation
- GF Health Products, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Omron Healthcare, Inc.
- Glenmark Pharmaceuticals
- PARI Respiratory Equipment, Inc.
- Koninklijke Philips N.V.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
4. Global Pulmonary Drug Delivery Systems Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Pulmonary Drug Delivery Systems Market, By Product Type, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Dry Powder Inhalers (DPIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Metered Dose Inhalers (MDIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Segment Trends
6. Global Pulmonary Drug Delivery Systems Market, By Application, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
7. Global Pulmonary Drug Delivery Systems Market, By Distribution Channel, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
8. Global Pulmonary Drug Delivery Systems Market, By Region, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- 3M Health Care
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allied Healthcare Products, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CareFusion Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GF Health Products, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Omron Healthcare, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PARI Respiratory Equipment, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
관련자료
